Location: Boston, MA
CIK: 0001595855 · Show all filings
Period: Q1 2019 (← Previous) (Next →)
Filing Date: May 15, 2019
Total Value: $361M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CDXS | CODEXIS INC | 1,475,000 | $30.28M | 8.4% | $3.21 | +504.9% | COM | 192005106 |
| AXGN | AXOGEN INC | 1,100,000 | $23.17M | 6.4% | $3.33 | +449.2% | COM | 05463X106 |
| — | EPIZYME INC | 1,365,000 | $16.91M | 4.7% | $8.49 | — | COM | 29428V104 |
| — | CERECOR INC | 2,300,000 | $13.43M | 3.7% | $2.99 | — | COM | 15671L109 |
| — | AMARIN CORP PLC | 645,000 | $13.39M | 3.7% | $3.50 | — | SPONSORED ADR | 023111206 |
| QURE | UNIQURE NV | 205,000 | $12.23M | 3.4% | $44.67 | 0.0% | SHS | N90064101 |
| ASND | ASCENDIS PHARMA A S | 95,000 | $11.18M | 3.1% | $117.71 | — | SPONSORED ADR | 04351P101 |
| TGTX | TG THERAPEUTICS INC | 1,366,062 | $10.98M | 3.0% | $7.37 | -26.7% | COM | 88322Q108 |
| — | AUDENTES THERAPEUTICS INC | 280,000 | $10.93M | 3.0% | $26.09 | — | COM | 05070R104 |
| — | FIBROGEN INC | 200,000 | $10.87M | 3.0% | $26.18 | — | COM | 31572Q808 |
| — | CLEMENTIA PHARMACEUTICALS INC | 400,130 | $10.44M | 2.9% | $20.50 | — | COM | 185575107 |
| — | BLUEPRINT MEDICINES CORP | 130,000 | $10.41M | 2.9% | $27.77 | — | COM | 09627Y109 |
| — | INVITAE CORP | 440,000 | $10.3M | 2.9% | $23.42 | — | COM | 46185L103 |
| CPRX | CATALYST PHARMACEUTICALS INC | 1,825,000 | $9.308M | 2.6% | $2.94 | 0.0% | COM | 14888U101 |
| — | HARROW HEALTH | 1,800,000 | $8.964M | 2.5% | $3.04 | — | COM | 45323A201 |
| — | MAGENTA THERAPEUTICS INC | 510,000 | $8.4M | 2.3% | $13.14 | — | COM | 55910K108 |
| PTCT | PTC THERAPEUTICS INC | 213,800 | $8.047M | 2.2% | $27.71 | +21.2% | COM | 69366J200 |
| — | DECIPHERA PHARMACEUTICALS IN | 340,000 | $7.891M | 2.2% | $22.57 | — | COM | 24344T101 |
| — | MIRATI THERAPEUTICS INC | 105,000 | $7.697M | 2.1% | $73.30 | — | COM | 60468T105 |
| OCUL | OCULAR THERAPEUTIX INC | 1,900,000 | $7.543M | 2.1% | $4.02 | 0.0% | COM | 67576A100 |
| — | CYMABAY THERAPEUTICS INC | 550,000 | $7.304M | 2.0% | $8.29 | — | COM | 23257D103 |
| — | ODONATE THERAPEUTICS INC | 325,000 | $7.186M | 2.0% | $20.90 | — | COM | 676079106 |
| — | CYTOKINETICS | 850,000 | $6.877M | 1.9% | $8.09 | — | COM NEW | 23282W905 |
| — | TRICIDA INC | 165,000 | $6.372M | 1.8% | $29.56 | — | COM | 89610F101 |
| ETON | ETON PHARMACEUTICALS INC | 764,773 | $6.118M | 1.7% | $6.39 | +8.7% | COM | 29772L108 |
| — | STRONGBRIDGE BIOPHARMA PLC | 1,152,500 | $5.739M | 1.6% | $4.28 | — | COM | G85347105 |
| — | DERMIRA INC | 400,000 | $5.42M | 1.5% | $13.05 | — | COM | 24983L104 |
| ACAD | ACADIA PHARMACEUTICALS INC | 200,000 | $5.37M | 1.5% | $15.92 | +46.7% | COM | 004225108 |
| XOMA | XOMA CORP DEL | 400,000 | $4.952M | 1.4% | $8.03 | +70.3% | COM NEW | 98419J206 |
| — | HORIZON PHARMA PLC | 185,000 | $4.89M | 1.4% | $26.43 | — | SHS | G4617B105 |
| VKTX | VIKING THERAPEUTICS INC | 485,000 | $4.821M | 1.3% | $4.57 | +83.1% | COM | 92686J106 |
| — | EIDOS THERAPEUTICS INC | 200,000 | $4.69M | 1.3% | $16.66 | — | COM | 28249H104 |
| — | RETROPHIN INC | 205,000 | $4.639M | 1.3% | $22.63 | — | COM | 761299106 |
| — | ABEONA THERAPEUTICS INC | 560,000 | $4.122M | 1.1% | $7.18 | — | COM | 00289Y107 |
| — | CARA THERAPEUTICS INC | 200,000 | $3.924M | 1.1% | $19.62 | — | COM | 140755109 |
| — | AVENUE THERAPEUTICS INC | 800,000 | $3.8M | 1.1% | $5.15 | — | COM NEW | 05360L205 |
| — | AIMMUNE THERAPEUTICS INC | 165,000 | $3.688M | 1.0% | $23.78 | — | COM | 00900T107 |
| — | FORTRESS BIOTECH INC | 2,000,000 | $3.56M | 1.0% | $1.78 | — | COM | 034960Q19 |
| — | ACORDA PHARMACEUTICALS | 265,000 | $3.522M | 1.0% | $13.29 | — | COM | 00484M106 |
| — | SHOCKWAVE MED INC | 92,100 | $3.083M | 0.9% | $33.47 | — | COM | 82489T104 |
| FENC | FENNEC PHARMACEUTICALS INC | 630,000 | $3.056M | 0.8% | $10.08 | -34.8% | COM | 31447P100 |
| — | CIDARA THERAPEUTICS INC | 1,000,000 | $2.65M | 0.7% | $5.20 | — | COM | 171757107 |
| LQDA | LIQUIDIA TECHNOLOGIES INC | 225,000 | $2.561M | 0.7% | $16.03 | 0.0% | COM | 53635D202 |
| APLS | APELLIS PHARMACEUTICALS INC | 115,000 | $2.243M | 0.6% | $21.66 | -27.4% | COM | 03753U106 |
| — | CHIMERIX INC | 960,000 | $2.016M | 0.6% | $3.93 | — | COM | 16934W106 |
| CRNX | CRINETICS PHARMACEUTICALS INC | 73,000 | $1.661M | 0.5% | $24.58 | 0.0% | COM | 22663K107 |
| ESTA | ESTABLISHMENT LABS HLDGS INC | 50,000 | $1.202M | 0.3% | $26.54 | 0.0% | COM | G31249108 |
| — | ZYMEWORKS INC | 55,000 | $890K | 0.2% | $14.68 | — | COM | 98985W102 |
| — | SYNTHORX INC | 40,000 | $815K | 0.2% | $20.38 | — | COM | 87167A103 |
| — | FOAMIX PHARMACEUTICALS LTD | 180,000 | $675K | 0.2% | $3.75 | — | SHS | M46135105 |
| KURA | KURA ONCOLOGY INC | 25,200 | $418K | 0.1% | $15.41 | 0.0% | COM | 50127T109 |
| — | LA JOLLA PHARMACEUTICAL CO | 60,000 | $386K | 0.1% | $6.43 | — | COM PAR $.0001 2 | 503459604 |
| — | BIOLINERX LTD | 250,000 | $108K | 0.0% | $1426.15 | — | SPONSORED ADR | 09071M106 |